---
figid: PMC10965438__gr15
figtitle: Macrophage membrane-coated nanomaterials and macrophage-based microrobot
  for the treatment of digestive system tumor
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10965438
filename: PMC10965438__gr15.jpg
figlink: /pmc/articles/PMC10965438/figure/F15
number: F15
caption: Macrophage membrane-coated nanomaterials and macrophage-based microrobot
  for the treatment of digestive system tumor.(A) Macrophage membrane-coated nanomaterials
  for the treatment of CRC. AB@LM targets CRC tissue and releases BPQD and Abemaciclib.
  Under NIR light irradiation, BPQD generates ROS to induce ICD and activate DC and
  effector T cells. Abemaciclib induces direct apoptosis of colon cancer cells and
  inhibition of Tregs [353]. Copyright 2022, American Chemical Society.(B) Macrophage
  membrane-coated nanomaterials for the treatment of pancreatic cancer. MPGNPs and
  erlotinib target tumor tissues. MPGNPs released Gem and inhibited DNA synthesis
  in pancreatic cancer cells by promoting the dFdCMP-dFdCDP-dFdCTP signaling pathway.
  Erlotinib binds to EGFR and activates the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling
  pathways, thereby inhibiting the proliferation of pancreatic cancer cells [354].
  Copyright 2021, American Chemical Society.(C) Macrophage-based microrobot for the
  treatment of CRC. Macrophages phagocytized PLGA-DTX-Fe3O4 to form a mixed-driven
  microrobot. Under the action of the EMA system, PLGA-DTX-Fe3O4 targets tumor spheres
  and delivers DTX, thereby leading to CRC cell apoptosis [356].Copyright 2016, Jiwon
  Han et al.(D) Macrophage-based microrobot for the treatment of pancreatic cancer.
  Macrophages engulf core/shell iron/iron oxide nanoparticles to form macrophage-based
  microrobots. Macrophage-based microrobots were injected into mice in a disseminated
  peritoneal pancreatic cancer model. Under the action of AMF, macrophage-based microrobots
  target the tumor tissue, generate heat, induce pancreatic cancer cell apoptosis,
  and promote immune cell infiltration. By FigDraw. CRC, Colorectal cancer; AB@LM,
  Artificial Assembled Macrophages; BPQD, Black phosphorus quantum dot; NIR, Near-infrared;
  ROS, Reactive oxygen species; ICD, Immunogenic cell death; DC, Dendritic cell; Tregs,
  Regulatory T cells; MPGNPs, Gemcitabine-loaded PLGA NPs with macrophage membrane
  coating; dFdCMP, Gemcitabine monophosphate; dFdCDP, Gemcitabine diphosphate; dFdCTP,
  gemcitabine triphosphate; EGFR, Epidermal Growth Factor Receptor; PI3K, Phosphoinositide
  3-kinase; AKT, AGC serine/threonine kinases; mTOR, Mammalian/mechanistic target
  of rapamycin; Ras, Rat sarcoma; Raf, Rapidly accelerated fibrosarcoma; MEK, Mitogen-activated
  protein kinase; ERK, Extracellular signal-regulated kinase; PLGA, Poly-lactic-co-glycolic-acid;
  DTX, Docetaxel; PLGA-DTX-Fe3O4 NPs, Poly-lactic-co-glycolic-acid-Docetaxel-Fe3O4
  nanoparticles
papertitle: Nanomaterials modulate tumor-associated macrophages for the treatment
  of digestive system tumorsâ˜†
reftext: Hao Li, et al. Bioact Mater. 2024 Jun;36(NA).
year: '2024'
doi: 10.1016/j.bioactmat.2024.03.003
journal_title: Bioactive Materials
journal_nlm_ta: Bioact Mater
publisher_name: KeAi Publishing
keywords: Digestive system tumors | Tumor-associated macrophages | Nanomaterials |
  Tumor immune microenvironment | Therapy
automl_pathway: 0.5326798
figid_alias: PMC10965438__F15
figtype: Figure
redirect_from: /figures/PMC10965438__F15
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10965438__gr15.html
  '@type': Dataset
  description: Macrophage membrane-coated nanomaterials and macrophage-based microrobot
    for the treatment of digestive system tumor.(A) Macrophage membrane-coated nanomaterials
    for the treatment of CRC. AB@LM targets CRC tissue and releases BPQD and Abemaciclib.
    Under NIR light irradiation, BPQD generates ROS to induce ICD and activate DC
    and effector T cells. Abemaciclib induces direct apoptosis of colon cancer cells
    and inhibition of Tregs [353]. Copyright 2022, American Chemical Society.(B) Macrophage
    membrane-coated nanomaterials for the treatment of pancreatic cancer. MPGNPs and
    erlotinib target tumor tissues. MPGNPs released Gem and inhibited DNA synthesis
    in pancreatic cancer cells by promoting the dFdCMP-dFdCDP-dFdCTP signaling pathway.
    Erlotinib binds to EGFR and activates the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling
    pathways, thereby inhibiting the proliferation of pancreatic cancer cells [354].
    Copyright 2021, American Chemical Society.(C) Macrophage-based microrobot for
    the treatment of CRC. Macrophages phagocytized PLGA-DTX-Fe3O4 to form a mixed-driven
    microrobot. Under the action of the EMA system, PLGA-DTX-Fe3O4 targets tumor spheres
    and delivers DTX, thereby leading to CRC cell apoptosis [356].Copyright 2016,
    Jiwon Han et al.(D) Macrophage-based microrobot for the treatment of pancreatic
    cancer. Macrophages engulf core/shell iron/iron oxide nanoparticles to form macrophage-based
    microrobots. Macrophage-based microrobots were injected into mice in a disseminated
    peritoneal pancreatic cancer model. Under the action of AMF, macrophage-based
    microrobots target the tumor tissue, generate heat, induce pancreatic cancer cell
    apoptosis, and promote immune cell infiltration. By FigDraw. CRC, Colorectal cancer;
    AB@LM, Artificial Assembled Macrophages; BPQD, Black phosphorus quantum dot; NIR,
    Near-infrared; ROS, Reactive oxygen species; ICD, Immunogenic cell death; DC,
    Dendritic cell; Tregs, Regulatory T cells; MPGNPs, Gemcitabine-loaded PLGA NPs
    with macrophage membrane coating; dFdCMP, Gemcitabine monophosphate; dFdCDP, Gemcitabine
    diphosphate; dFdCTP, gemcitabine triphosphate; EGFR, Epidermal Growth Factor Receptor;
    PI3K, Phosphoinositide 3-kinase; AKT, AGC serine/threonine kinases; mTOR, Mammalian/mechanistic
    target of rapamycin; Ras, Rat sarcoma; Raf, Rapidly accelerated fibrosarcoma;
    MEK, Mitogen-activated protein kinase; ERK, Extracellular signal-regulated kinase;
    PLGA, Poly-lactic-co-glycolic-acid; DTX, Docetaxel; PLGA-DTX-Fe3O4 NPs, Poly-lactic-co-glycolic-acid-Docetaxel-Fe3O4
    nanoparticles
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NOC2L
  - NPS
  - GNPTAB
  - ATP8A2
  - CALCR
  - CALR
  - SLC6A8
  - HMGB1
  - IK
  - DYRK3
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - PLGA
  - PDT
  - PTT
  - ATP
  - CRT
  - Gemcitabine
  - Erlotinib
  - Ras
  - MEK
  - cancer
  - Pancreatic cancer
---
